AIFM3 and cholangiocarcinoma: The key findings involve a significant reduction in AIFM3-positive cells in the lamina propria, especially in advanced CRC stages (Dukes B–D), contrasting with increased AIFM3 levels in breast cancer and cholangiocarcinoma.